Understand the source comparison
Platform Comparison: Mass Spectrometry vs. Immunoassays
Mass spectrometry stands out for its multiplexing capabilities and high specificity. Modern MS instruments can detect peptides at levels ranging from low nanomoles to attomoles, depending on the peptide. Another advantage is the flexibility to add new analytes
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Mass spectrometry stands out for its multiplexing capabilities and high specificity. Modern MS instruments can detect peptides at levels ranging from low nanomoles to attomoles, depending on the peptide. Another advantage is the flexibility to add new analytes to existing panels within weeks or months, provided you have the target and matrix protein sequence information. On the other hand, immunoassays, such as ELISA, Luminex, and MSD platforms, require significantly more time to develop. Polyclonal antibodies may take months, while monoclonal antibodies can take years to produce.
- Immunoassays, however, excel in sensitivity. ELISA kits, for example, can quantify down to 0.1–1 ng/mL, with some multiplexing assays achieving even lower detection limits of 0.05 ng/mL. Luminex assays offer dynamic ranges spanning up to five orders of magnitude, while MSD platforms combine ultralow detection limits with similarly broad dynamic ranges.
- Development Time
- Months for polyclonal, years for monoclonal antibodies
- Weeks to months with sequence information
- Sensitivity
- 0.05–1 ng/mL
- Low nanomole to attomole levels
- Sample Preparation
- Minimal cleanup; avoids harsh reagents
- Requires additional treatment; tolerates harsh reagents
- Technical Expertise
- Easier to implement in basic labs
- Requires advanced expertise for interpretation
- Cost Structure
- Lower upfront costs; higher multiplexing costs
- High initial costs; potential savings during development
- Matrix Compatibility
- Susceptible to matrix effects
- Internal standards help normalize matrix effects
- Mass spectrometry demands advanced technical skills, while immunoassays are more approachable for labs with less specialized expertise. These platform-specific traits influence everything from buffer formulation to detection strategies.